1	2	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Follicular	_	_	JJ	_	_	_	_	_
2	Ovarian	_	_	NNP	_	_	_	_	_
3	Reserve	_	_	NNP	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	Its	_	_	PRP$	_	_	_	_	_
6	Regulation	_	_	NN	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	mammals	_	_	NNS	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	follicular	_	_	JJ	_	_	_	_	_
6	ovarian	_	_	NN	_	_	_	_	_
7	reserve	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	constituted	_	_	VBN	_	_	_	_	_
10	by	_	_	IN	_	_	_	_	_
11	primordial	_	_	JJ	_	_	_	_	_
12	follicles	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	is	_	_	VBZ	_	_	_	_	_
15	established	_	_	VBN	_	_	_	_	_
16	early	_	_	RB	_	_	_	_	_
17	on	_	_	IN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	life	_	_	NN	_	_	_	_	_
20	then	_	_	RB	_	_	_	_	_
21	keeps	_	_	VBZ	_	_	_	_	_
22	declining	_	_	VBG	_	_	_	_	_
23	regularly	_	_	RB	_	_	_	_	_
24	throughout	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	reproductive	_	_	JJ	_	_	_	_	_
27	period	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	pool	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	primordial	_	_	JJ	_	_	_	_	_
5	follicles	_	_	NNS	_	_	_	_	_
6	serves	_	_	VBZ	_	_	_	_	_
7	as	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	source	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	growing	_	_	VBG	_	_	_	_	_
12	follicles	_	_	NNS	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	fertilizable	_	_	JJ	_	_	_	_	_
15	eggs	_	_	NNS	_	_	_	_	_
16	for	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	entire	_	_	JJ	_	_	_	_	_
19	female	_	_	JJ	_	_	_	_	_
20	reproductive	_	_	JJ	_	_	_	_	_
21	life	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Actually	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	each	_	_	DT	_	_	_	_	_
4	primordial	_	_	JJ	_	_	_	_	_
5	follicle	_	_	NN	_	_	_	_	_
6	can	_	_	MD	_	_	_	_	_
7	remain	_	_	VB	_	_	_	_	_
8	quiescent	_	_	JJ	_	_	_	_	_
9	for	_	_	IN	_	_	_	_	_
10	years	_	_	NNS	_	_	_	_	_
11	;	_	_	:	_	_	_	_	_
12	be	_	_	VB	_	_	_	_	_
13	activated	_	_	VBN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	enter	_	_	VB	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	growing	_	_	VBG	_	_	_	_	_
18	process	_	_	NN	_	_	_	_	_
19	;	_	_	:	_	_	_	_	_
20	or	_	_	CC	_	_	_	_	_
21	undergo	_	_	VB	_	_	_	_	_
22	atresia	_	_	NN	_	_	_	_	_
23	directly	_	_	RB	_	_	_	_	_
24	from	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	dormant	_	_	JJ	_	_	_	_	_
27	stage	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	produce	_	_	VB	_	_	_	_	_
3	mature	_	_	JJ	_	_	_	_	_
4	oocytes	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	activated	_	_	VBN	_	_	_	_	_
7	primordial	_	_	JJ	_	_	_	_	_
8	follicles	_	_	NNS	_	_	_	_	_
9	develop	_	_	VBP	_	_	_	_	_
10	through	_	_	IN	_	_	_	_	_
11	primary	_	_	JJ	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	secondary	_	_	JJ	_	_	_	_	_
14	stages	_	_	NNS	_	_	_	_	_
15	before	_	_	IN	_	_	_	_	_
16	acquiring	_	_	VBG	_	_	_	_	_
17	an	_	_	DT	_	_	_	_	_
18	antral	_	_	JJ	_	_	_	_	_
19	cavity	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	At	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	antral	_	_	JJ	_	_	_	_	_
4	stage	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	most	_	_	JJS	_	_	_	_	_
7	follicles	_	_	NNS	_	_	_	_	_
8	undergo	_	_	VBP	_	_	_	_	_
9	apoptotic	_	_	JJ	_	_	_	_	_
10	degeneration	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	only	_	_	RB	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	few	_	_	JJ	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	them	_	_	PRP	_	_	_	_	_
17	grow	_	_	VBP	_	_	_	_	_
18	further	_	_	RBR	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	reach	_	_	VB	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	preovulatory	_	_	JJ	_	_	_	_	_
23	stage	_	_	NN	_	_	_	_	_
24	under	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	cyclic	_	_	JJ	_	_	_	_	_
27	gonadotropin	_	_	NN	_	_	_	_	_
28	stimulation	_	_	NN	_	_	_	_	_
29	that	_	_	WDT	_	_	_	_	_
30	occurs	_	_	VBZ	_	_	_	_	_
31	after	_	_	IN	_	_	_	_	_
32	puberty	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	maintenance	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	female	_	_	JJ	_	_	_	_	_
5	reproductive	_	_	JJ	_	_	_	_	_
6	function	_	_	NN	_	_	_	_	_
7	implies	_	_	VBZ	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	presence	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	vast	_	_	JJ	_	_	_	_	_
13	majority	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	quiescent	_	_	JJ	_	_	_	_	_
16	primordial	_	_	JJ	_	_	_	_	_
17	follicles	_	_	NNS	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	continuous	_	_	JJ	_	_	_	_	_
20	repression	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	primordial	_	_	JJ	_	_	_	_	_
23	follicle	_	_	NN	_	_	_	_	_
24	activation	_	_	NN	_	_	_	_	_
25	into	_	_	IN	_	_	_	_	_
26	early	_	_	JJ	_	_	_	_	_
27	growing	_	_	VBG	_	_	_	_	_
28	follicles	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	activation	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	starting	_	_	VBG	_	_	_	_	_
5	during	_	_	IN	_	_	_	_	_
6	fetal	_	_	JJ	_	_	_	_	_
7	life	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	is	_	_	VBZ	_	_	_	_	_
10	finely	_	_	RB	_	_	_	_	_
11	controlled	_	_	VBN	_	_	_	_	_
12	though	_	_	IN	_	_	_	_	_
13	maintaining	_	_	VBG	_	_	_	_	_
14	a	_	_	DT	_	_	_	_	_
15	balance	_	_	NN	_	_	_	_	_
16	between	_	_	IN	_	_	_	_	_
17	inhibitory	_	_	JJ	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	stimulatory	_	_	JJ	_	_	_	_	_
20	factors	_	_	NNS	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	vitro	_	_	NN	_	_	_	_	_
3	experiments	_	_	NNS	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	genetically	_	_	RB	_	_	_	_	_
6	modified	_	_	VBN	_	_	_	_	_
7	mouse	_	_	NN	_	_	_	_	_
8	or	_	_	CC	_	_	_	_	_
9	sheep	_	_	NN	_	_	_	_	_
10	models	_	_	NNS	_	_	_	_	_
11	have	_	_	VBP	_	_	_	_	_
12	enabled	_	_	VBN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	decoding	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	molecular	_	_	JJ	_	_	_	_	_
18	mechanisms	_	_	NNS	_	_	_	_	_
19	that	_	_	WDT	_	_	_	_	_
20	control	_	_	VBP	_	_	_	_	_
21	follicular	_	_	JJ	_	_	_	_	_
22	activation	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Numerous	_	_	JJ	_	_	_	_	_
2	factors	_	_	NNS	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	such	_	_	JJ	_	_	_	_	_
5	as	_	_	IN	_	_	_	_	_
6	growth	_	_	NN	_	_	_	_	_
7	factors	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	hormones	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	transcription	_	_	NN	_	_	_	_	_
12	factors	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	or	_	_	CC	_	_	_	_	_
15	cytokines	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	produced	_	_	VBN	_	_	_	_	_
18	by	_	_	IN	_	_	_	_	_
19	oocytes	_	_	NNS	_	_	_	_	_
20	and/or	_	_	CC	_	_	_	_	_
21	granulosa	_	_	NN	_	_	_	_	_
22	cells	_	_	NNS	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	can	_	_	MD	_	_	_	_	_
25	act	_	_	VB	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	an	_	_	DT	_	_	_	_	_
28	autocrine	_	_	JJ	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	paracrine	_	_	NN	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	or	_	_	CC	_	_	_	_	_
33	endocrine	_	_	JJ	_	_	_	_	_
34	manner	_	_	NN	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	quiescence	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	primordial	_	_	JJ	_	_	_	_	_
5	follicles	_	_	NNS	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	maintained	_	_	VBN	_	_	_	_	_
8	by	_	_	IN	_	_	_	_	_
9	several	_	_	JJ	_	_	_	_	_
10	molecules	_	_	NNS	_	_	_	_	_
11	including	_	_	VBG	_	_	_	_	_
12	phosphatase	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	tensin	_	_	NN	_	_	_	_	_
15	homolog	_	_	NN	_	_	_	_	_
16	deleted	_	_	VBN	_	_	_	_	_
17	on	_	_	IN	_	_	_	_	_
18	chromosome	_	_	NN	_	_	_	_	_
19	10	_	_	CD	_	_	_	_	_
20	(	_	_	-LRB-	_	_	_	_	_
21	Pten	_	_	NN	_	_	_	_	_
22	)	_	_	-RRB-	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	tuberous	_	_	JJ	_	_	_	_	_
25	sclerosis	_	_	NN	_	_	_	_	_
26	complexes	_	_	NNS	_	_	_	_	_
27	1	_	_	CD	_	_	_	_	_
28	–	_	_	NN	_	_	_	_	_
29	2	_	_	CD	_	_	_	_	_
30	(	_	_	-LRB-	_	_	_	_	_
31	Tsc1	_	_	NN	_	_	_	_	_
32	–	_	_	NN	_	_	_	_	_
33	Tsc2	_	_	NN	_	_	_	_	_
34	)	_	_	-RRB-	_	_	_	_	_
35	complex	_	_	NN	_	_	_	_	_
36	,	_	_	,	_	_	_	_	_
37	Forkhead	_	_	NNP	_	_	_	_	_
38	box	_	_	NN	_	_	_	_	_
39	protein	_	_	NN	_	_	_	_	_
40	O3A	_	_	NNP	_	_	_	_	_
41	(	_	_	-LRB-	_	_	_	_	_
42	Foxo3A	_	_	NN	_	_	_	_	_
43	)	_	_	-RRB-	_	_	_	_	_
44	,	_	_	,	_	_	_	_	_
45	p27	_	_	NN	_	_	_	_	_
46	,	_	_	,	_	_	_	_	_
47	anti-Müllerian	_	_	JJ	_	_	_	_	_
48	hormone	_	_	NN	_	_	_	_	_
49	(	_	_	-LRB-	_	_	_	_	_
50	AMH	_	_	NN	_	_	_	_	_
51	)	_	_	-RRB-	_	_	_	_	_
52	,	_	_	,	_	_	_	_	_
53	and	_	_	CC	_	_	_	_	_
54	Forkhead	_	_	NNP	_	_	_	_	_
55	box	_	_	NN	_	_	_	_	_
56	L2	_	_	NN	_	_	_	_	_
57	(	_	_	-LRB-	_	_	_	_	_
58	FoxL2	_	_	NNP	_	_	_	_	_
59	)	_	_	-RRB-	_	_	_	_	_
60	.	_	_	.	_	_	_	_	_


1	Many	_	_	JJ	_	_	_	_	_
2	studies	_	_	NNS	_	_	_	_	_
3	have	_	_	VBP	_	_	_	_	_
4	highlighted	_	_	VBN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	crucial	_	_	JJ	_	_	_	_	_
7	roles	_	_	NNS	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	phosphatidyl-inositol-3-kinase	_	_	NN	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_
12	PI3K	_	_	NNP	_	_	_	_	_
13	)	_	_	-RRB-	_	_	_	_	_
14	signaling	_	_	NN	_	_	_	_	_
15	pathway	_	_	NN	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	oocytes	_	_	NNS	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	controlling	_	_	VBG	_	_	_	_	_
20	follicular	_	_	JJ	_	_	_	_	_
21	activation	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Indeed	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	genetically	_	_	RB	_	_	_	_	_
5	modified	_	_	VBN	_	_	_	_	_
6	mouse	_	_	NN	_	_	_	_	_
7	models	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	it	_	_	PRP	_	_	_	_	_
10	was	_	_	VBD	_	_	_	_	_
11	observed	_	_	VBN	_	_	_	_	_
12	that	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	PI3K	_	_	NNP	_	_	_	_	_
15	–	_	_	:	_	_	_	_	_
16	Akt	_	_	NNP	_	_	_	_	_
17	–	_	_	:	_	_	_	_	_
18	mammalian	_	_	JJ	_	_	_	_	_
19	target	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	rapamycin	_	_	NN	_	_	_	_	_
22	(	_	_	-LRB-	_	_	_	_	_
23	mTOR	_	_	NN	_	_	_	_	_
24	)	_	_	-RRB-	_	_	_	_	_
25	signaling	_	_	VBG	_	_	_	_	_
26	pathway	_	_	NN	_	_	_	_	_
27	is	_	_	VBZ	_	_	_	_	_
28	crucial	_	_	JJ	_	_	_	_	_
29	for	_	_	IN	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	control	_	_	NN	_	_	_	_	_
32	of	_	_	IN	_	_	_	_	_
33	survival	_	_	NN	_	_	_	_	_
34	and	_	_	CC	_	_	_	_	_
35	activation	_	_	NN	_	_	_	_	_
36	of	_	_	IN	_	_	_	_	_
37	primordial	_	_	JJ	_	_	_	_	_
38	follicles	_	_	NNS	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	example	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	Pten	_	_	NNP	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	Tsc1	_	_	NNP	_	_	_	_	_
7	–	_	_	:	_	_	_	_	_
8	2	_	_	CD	_	_	_	_	_
9	are	_	_	VBP	_	_	_	_	_
10	negative	_	_	JJ	_	_	_	_	_
11	regulators	_	_	NNS	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	this	_	_	DT	_	_	_	_	_
14	signaling	_	_	VBG	_	_	_	_	_
15	pathway	_	_	NN	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	mice	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	deletion	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	these	_	_	DT	_	_	_	_	_
25	genes	_	_	NNS	_	_	_	_	_
26	from	_	_	IN	_	_	_	_	_
27	oocytes	_	_	NNS	_	_	_	_	_
28	leads	_	_	VBZ	_	_	_	_	_
29	to	_	_	TO	_	_	_	_	_
30	primordial	_	_	JJ	_	_	_	_	_
31	follicle	_	_	NN	_	_	_	_	_
32	activation	_	_	NN	_	_	_	_	_
33	and	_	_	CC	_	_	_	_	_
34	subsequent	_	_	JJ	_	_	_	_	_
35	early	_	_	JJ	_	_	_	_	_
36	follicular	_	_	JJ	_	_	_	_	_
37	depletion	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	these	_	_	DT	_	_	_	_	_
3	models	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	mTOR	_	_	NN	_	_	_	_	_
6	activity	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	accelerated	_	_	VBN	_	_	_	_	_
9	within	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	oocyte	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	highlighting	_	_	VBG	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	critical	_	_	JJ	_	_	_	_	_
16	role	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	this	_	_	DT	_	_	_	_	_
19	serine/threonine	_	_	NN	_	_	_	_	_
20	kinase	_	_	NN	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	primordial	_	_	JJ	_	_	_	_	_
23	follicle	_	_	NN	_	_	_	_	_
24	activation	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	transcription	_	_	NN	_	_	_	_	_
3	factor	_	_	NN	_	_	_	_	_
4	FoxO3A	_	_	NNP	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	mainly	_	_	RB	_	_	_	_	_
7	expressed	_	_	VBN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	oocytes	_	_	NNS	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	resting	_	_	VBG	_	_	_	_	_
13	follicles	_	_	NNS	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	acts	_	_	VBZ	_	_	_	_	_
16	downstream	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	PI3K	_	_	NNP	_	_	_	_	_
20	signaling	_	_	VBG	_	_	_	_	_
21	pathway	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	appears	_	_	VBZ	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	be	_	_	VB	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	main	_	_	JJ	_	_	_	_	_
28	actor	_	_	NN	_	_	_	_	_
29	involved	_	_	VBN	_	_	_	_	_
30	in	_	_	IN	_	_	_	_	_
31	follicular	_	_	JJ	_	_	_	_	_
32	activation	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	At	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	same	_	_	JJ	_	_	_	_	_
4	time	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	survival	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	primordial	_	_	JJ	_	_	_	_	_
10	follicles	_	_	NNS	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	maintained	_	_	VBN	_	_	_	_	_
13	by	_	_	IN	_	_	_	_	_
14	other	_	_	JJ	_	_	_	_	_
15	mechanisms	_	_	NNS	_	_	_	_	_
16	involving	_	_	VBG	_	_	_	_	_
17	PDK1	_	_	NN	_	_	_	_	_
18	signaling	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	rpS6	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	Several	_	_	JJ	_	_	_	_	_
2	studies	_	_	NNS	_	_	_	_	_
3	have	_	_	VBP	_	_	_	_	_
4	suggested	_	_	VBN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	involvement	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	autophagy	_	_	NN	_	_	_	_	_
10	process	_	_	NN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	regulation	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	ovarian	_	_	JJ	_	_	_	_	_
17	reserve	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	primordial	_	_	JJ	_	_	_	_	_
20	follicles	_	_	NNS	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	example	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	autophagy	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	implicated	_	_	VBN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	maintaining	_	_	VBG	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	primordial	_	_	JJ	_	_	_	_	_
11	oocyte	_	_	NN	_	_	_	_	_
12	pool	_	_	NN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	murine	_	_	NN	_	_	_	_	_
15	newborns	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	induction	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	autophagy	_	_	NN	_	_	_	_	_
22	at	_	_	IN	_	_	_	_	_
23	birth	_	_	NN	_	_	_	_	_
24	seems	_	_	VBZ	_	_	_	_	_
25	to	_	_	TO	_	_	_	_	_
26	be	_	_	VB	_	_	_	_	_
27	a	_	_	DT	_	_	_	_	_
28	crucial	_	_	JJ	_	_	_	_	_
29	step	_	_	NN	_	_	_	_	_
30	to	_	_	TO	_	_	_	_	_
31	preserve	_	_	VB	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	stock	_	_	NN	_	_	_	_	_
34	of	_	_	IN	_	_	_	_	_
35	primordial	_	_	JJ	_	_	_	_	_
36	follicles	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	same	_	_	JJ	_	_	_	_	_
4	manner	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	primordial	_	_	JJ	_	_	_	_	_
7	follicle	_	_	NN	_	_	_	_	_
8	survival	_	_	NN	_	_	_	_	_
9	or	_	_	CC	_	_	_	_	_
10	apoptosis	_	_	NN	_	_	_	_	_
11	results	_	_	VBZ	_	_	_	_	_
12	from	_	_	IN	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	balance	_	_	NN	_	_	_	_	_
15	between	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	expression	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	survival	_	_	NN	_	_	_	_	_
20	(	_	_	-LRB-	_	_	_	_	_
21	antiapoptotic	_	_	JJ	_	_	_	_	_
22	)	_	_	-RRB-	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	proapoptotic	_	_	JJ	_	_	_	_	_
25	factors	_	_	NNS	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Among	_	_	IN	_	_	_	_	_
2	these	_	_	DT	_	_	_	_	_
3	factors	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	proteins	_	_	NNS	_	_	_	_	_
7	B-cell	_	_	NN	_	_	_	_	_
8	lymphoma	_	_	NN	_	_	_	_	_
9	2	_	_	CD	_	_	_	_	_
10	(	_	_	-LRB-	_	_	_	_	_
11	Bcl-2	_	_	NNP	_	_	_	_	_
12	)	_	_	-RRB-	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	Bcl-2-associated	_	_	JJ	_	_	_	_	_
15	X	_	_	NN	_	_	_	_	_
16	protein	_	_	NN	_	_	_	_	_
17	(	_	_	-LRB-	_	_	_	_	_
18	BAX	_	_	NNP	_	_	_	_	_
19	)	_	_	-RRB-	_	_	_	_	_
20	likely	_	_	RB	_	_	_	_	_
21	play	_	_	VB	_	_	_	_	_
22	a	_	_	DT	_	_	_	_	_
23	critical	_	_	JJ	_	_	_	_	_
24	role	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Thus	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	synergistic	_	_	JJ	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	coordinated	_	_	JJ	_	_	_	_	_
7	suppression	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	follicular	_	_	JJ	_	_	_	_	_
10	activation	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	provided	_	_	VBN	_	_	_	_	_
13	by	_	_	IN	_	_	_	_	_
14	multiple	_	_	JJ	_	_	_	_	_
15	inhibitory	_	_	JJ	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	activator	_	_	NN	_	_	_	_	_
18	molecules	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	is	_	_	VBZ	_	_	_	_	_
21	necessary	_	_	JJ	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	preserve	_	_	VB	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	primordial	_	_	JJ	_	_	_	_	_
26	follicular	_	_	JJ	_	_	_	_	_
27	stockpile	_	_	NN	_	_	_	_	_
28	in	_	_	IN	_	_	_	_	_
29	association	_	_	NN	_	_	_	_	_
30	with	_	_	IN	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	process	_	_	NN	_	_	_	_	_
33	maintaining	_	_	VBG	_	_	_	_	_
34	dormancy	_	_	NN	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	Any	_	_	DT	_	_	_	_	_
2	disorder	_	_	NN	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	these	_	_	DT	_	_	_	_	_
5	complex	_	_	JJ	_	_	_	_	_
6	mechanisms	_	_	NNS	_	_	_	_	_
7	can	_	_	MD	_	_	_	_	_
8	lead	_	_	VB	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	premature	_	_	JJ	_	_	_	_	_
12	loss	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	follicular	_	_	JJ	_	_	_	_	_
16	reserve	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_

